Related Experiment Videos
[Treatment of infections caused by group A beta-hemolytic streptococci]
A Halstensen1, P Brandtzaeg, M Andrew
1Medisinsk avdeling B, Haukeland sykehus, Bergen.
Abstract:
Since 1987 the number of severe and fatal cases of group A-beta-hemolytic streptococci (GAS) infections has increased in Scandinavia. It therefore seems reasonable to stress the monitoring, diagnosis and treatment of infections caused by GAS. Treatment with phenoxymethylpenicillin for ten days is recommended for patients with uncomplicated disease. Patients with severe disease should be treated with benzylpenicillin intravenously. We discuss alternative antibiotics, treatment of immunological complications, and general hygienic precautions.
Insights
Group A-beta-hemolytic streptococci (GAS) infections are rising in Scandinavia. Prompt diagnosis and treatment with penicillin are crucial for managing both uncomplicated and severe GAS cases.
Area of Science:
- Microbiology
- Infectious Diseases
- Epidemiology
Context:
- Increasing incidence of severe and fatal Group A-beta-hemolytic streptococci (GAS) infections observed in Scandinavia since 1987.
- Growing public health concern necessitates enhanced surveillance, diagnostic accuracy, and therapeutic strategies for GAS infections.
Purpose:
- To highlight the escalating threat of GAS infections in Scandinavia.
- To recommend optimal treatment protocols for GAS infections, differentiating between uncomplicated and severe cases.
- To provide guidance on managing complications and implementing preventive measures.
Summary:
- Phenoxymethylpenicillin is the recommended ten-day treatment for uncomplicated GAS disease.
- Intravenous benzylpenicillin is advised for patients presenting with severe GAS infections.
- The abstract also touches upon alternative antibiotic choices, management of associated immunological complications, and essential hygienic practices.
Impact:
- Improved patient outcomes through timely and appropriate GAS infection management.
- Reduced morbidity and mortality associated with severe GAS infections.
- Enhanced public health preparedness for streptococcal outbreaks through standardized monitoring and treatment guidelines.